Polypharmacy and Major Adverse Events in Atrial Fibrillation.
Tsagkaris C, Papazoglou AS, Kartas A, Samaras A, Moysidis DV, Vouloagkas I, Baroutidou A, Bekiaridou A, Patsiou V, Chatzisolomou A, Panteris E, Karagiannidis E, Karvounis H, Tzikas A, Giannakoulas G.
Tsagkaris C, et al. Among authors: patsiou v.
J Cardiovasc Pharmacol. 2022 Dec 1;80(6):826-831. doi: 10.1097/FJC.0000000000001339.
J Cardiovasc Pharmacol. 2022.
PMID: 35921643